https://medicaldialogues.in/news/industry/pharma/usfda-grants-fast-track-designation-to-jnj-nipocalimab-to-reduce-fetal-neonatal-alloimmune-thrombocytopenia-risk-in-alloimmunized-pregnant-adults-126353